Pan Z, Zhang J, Cheng H, Bu Q, Li N, Deng Y, et al. Trends of the incidence of Drug Use Disorders from 1990 to 2017: an analysis based on the global burden of Disease 2017 data. Epidemiol Psychiatr Sci. 2020;29:e148.
Article PubMed PubMed Central Google Scholar
International Classification of Diseases 11th Revision. The global standard for diagnostic health information. [Internet]. World Health Organization. [cited 2023 Jan 9]. Available from: https://icd.who.int/browse11/l-m/en.
Association AP, Force APAD- 5 T, editors. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Association; 2013.
Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Psychiatry [Internet]. 2018 Dec 1;5(12):987–1012. Available from: https://doi.org/10.1016/S2215-0366(18)30337-7
Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet (London England). 2019;394(10208):1560–79.
Article CAS PubMed Google Scholar
Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict Behav. 2014;39(3):520–31.
Santo TJ, Campbell G, Gisev N, Martino-Burke D, Wilson J, Colledge-Frisby S, et al. Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis. Drug Alcohol Depend. 2022;238:109551.
Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci. 2015;17(3):337–46.
Article PubMed PubMed Central Google Scholar
Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other Drug Use Disorders: treatment efficacy by contrast condition. J Consult Clin Psychol. 2019;87(12):1093–105.
Article PubMed PubMed Central Google Scholar
Habibi R, Nikbakht Nasrabadi A, Shabany Hamedan M, Saleh Moqadam A. The effects of Family-centered problem-solving education on Relapse Rate, Self Efficacy and Self Esteem among Substance abusers. Int J high risk Behav Addict. 2016;5(1):e24421.
Article PubMed PubMed Central Google Scholar
Kiluk BD, Nich C, Babuscio T, Carroll KM. Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction. 2010;105(12):2120–7.
Article PubMed PubMed Central Google Scholar
Kiluk BD. Computerized cognitive behavioral therapy for Substance Use disorders: a Summary of the evidence and potential mechanisms of Behavior Change. Perspect Behav Sci. 2019;42(3):465–78.
Article PubMed PubMed Central Google Scholar
Zakeri R, Pashang B. Comparisson effectiveness of cognitive behavioral therapy and buspirone-based treatment in reducing temptation of Opium addicts. Indian J Fundam Appl Life Sci. 2014;4(4):2398–402.
Cully JA, Teten AL. A T H E R A P I S T ’ S, G U I D E To. BRIEF COGNITIVE BEHAVIORAL THERAPY. Dep Veterans Aff South Cent MIRECC [Internet]. 2008;111. Available from: papers3://publication/uuid/511A96F5-439A-403D-BB8C-C85BE1A99789.
Greer JA, Traeger L, Bemis H, Solis J, Hendriksen ES, Park ER, et al. A pilot randomized controlled trial of brief cognitive-behavioral therapy for anxiety in patients with terminal cancer. Oncologist. 2012;17(10):1337–45.
Article PubMed PubMed Central Google Scholar
Cully JA, Hundt NE, Fletcher T, Sansgiry S, Zeno D, Kauth MR et al. Brief cognitive-behavioral therapy for Depression in Community clinics: a hybrid effectiveness-implementation trial. Psychiatr Serv. 2023;appips20220582.
Hoskins JI, Blood L, Stokes HR, Tatham M, Waller G, Turner H. Patients’ experiences of brief cognitive behavioral therapy for eating disorders: a qualitative investigation. Int J Eat Disord. 2019;52(5):530–7.
Liu Y, Yang X, Gillespie A, Guo Z, Ma Y, Chen R, et al. Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: a pilot randomized controlled study. Psychiatry Res. 2019;272:275–83.
Beehler GP, Loughran TA, King PR, Dollar KM, Murphy JL, Kearney LK, et al. Patients’ perspectives of brief cognitive behavioral therapy for chronic pain: treatment satisfaction, perceived utility, and global assessment of change. Fam Syst Health. 2021;39(2):351–7.
Bishop TM, Crean HF, Funderburk JS, Pigeon WR. Initial Session effects of brief cognitive behavioral therapy for Insomnia: a secondary analysis of a small Randomized Pilot Trial. Behav Sleep Med. 2021;19(6):769–82.
Alammehrjerdi Z, Briggs NE, Biglarian A, Mokri A, Dolan K. A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment. J Psychoactive Drugs [Internet]. 2019;51(3):280–9. https://doi.org/10.1080/02791072.2019.1578445.
Saulle R, Vecchi S, Gowing L. Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database Syst Rev. 2017;4(4):CD011983.
Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA Netw Open [Internet]. 2020;3(6):e208279–e208279. https://doi.org/10.1001/jamanetworkopen.2020.8279.
Serdar CC, Cihan M, Yücel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med. 2021;31(1):10502.
Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9(1):139–45.
Article CAS PubMed Google Scholar
Vergara-Moragues E, González-Saiz F. Predictive Outcome Validity of General Health Questionnaire (GHQ-28) in substance abuse patients treated in therapeutic communities. J Dual Diagn. 2020;16(2):218–27.
Nazifi M, Mokarami HR, Akbaritabar AK, Faraji Kujerdi M, Tabrizi R, Rahi A, Reliability. Validity and Factor Structure of the Persian Translation of General Health Questionnire (GHQ-28) in Hospitals of Kerman University of Medical Sciences. JABS [Internet]. 2013;3(4):336–42. Available from: http://jabs.fums.ac.ir/article-1-528-en.html.
Montazeri A, Harirchi AM, Shariati M, Garmaroudi G, Ebadi M, Fateh A. The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1:66.
Article PubMed PubMed Central Google Scholar
Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22 140:55.
Hjelle EG, Bragstad LK, Zucknick M, Kirkevold M, Thommessen B, Sveen U. The General Health Questionnaire-28 (GHQ-28) as an outcome measurement in a randomized controlled trial in a Norwegian stroke population. BMC Psychol [Internet]. 2019;7(1):18. https://doi.org/10.1186/s40359-019-0293-0.
Sitnikova K, Leone SS, van Marwijk HWJ, Twisk J, van der Horst HE, van der Wouden JC. Effectiveness of a cognitive behavioural intervention for patients with undifferentiated somatoform disorder: Results from the CIPRUS cluster randomized controlled trial in primary care. J Psychosom Res [Internet]. 2019;127:109745. Available from: https://www.sciencedirect.com/science/article/pii/S0022399919301928.
Liu J, Gill NS, Teodorczuk A, Li Z-J, Sun J. The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: a meta-analysis of randomized controlled trials. J Affect Disord. 2019;245:98–112.
Zhang B, Ding X, Lu W, Zhao J, Lv Q, Yi Z, et al. Effect of group cognitive-behavioral therapy on the quality of life and social functioning of patients with mild depression. Shanghai Arch Psychiatry. 2016;28(1):18–27.
PubMed PubMed Central Google Scholar
kamarzarin hamid, golestani ehsan. The effectiveness of CBT on methadone consumption and general health in Opium addicts. Iran J Heal Psychol [Internet]. 2019;2(2):81–8. Available from: https://ijohp.journals.pnu.ac.ir/article_6777.html.
Bador K, Kerekes N. Evaluation of an Integrated Intensive Cognitive Behavioral Therapy Treatment within Addiction Care. J Behav Health Serv Res. 2020;47(1):102–12.
Speed TJ, Hanks L, Turner G, Gurule E, Kearson A, Buenaver L, et al. A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community: a RE-AIM framework evaluation. Trials. 2022;23(1):965.
Article PubMed PubMed Central Google Scholar
Babson KA, Ramo DE, Baldini L, Vandrey R, Bonn-Miller MO. Mobile App-delivered cognitive behavioral therapy for Insomnia: feasibility and initial efficacy among Veterans with Cannabis Use disorders. JMIR Res Protoc. 2015;4(3):e87.
Article PubMed PubMed Central Google Scholar
Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of Meta-analyses. Cognit Ther Res. 2012;36(5):427–40.
Article PubMed PubMed Central Google Scholar
Cully JA, Stanley MA, Petersen NJ, Hundt NE, Kauth MR, Naik AD, et al. Delivery of brief cognitive behavioral therapy for medically Ill patients in primary care: a pragmatic Randomized Clinical Trial. J Gen Intern Med. 2017;32(9):1014–24.
Article PubMed PubMed Central Google Scholar
Golshani F, Mirghafourvand M, Hasanpour S, Seiiedi Biarag L. The Effect of Cognitive Behavioral Therapy on Anxiety and Depression in Iranian Infertile Women: A Systematic and Meta-Analytical Review. Iran J Psychiatry Behav Sci [Internet]. 2020;14(1):e96715. Available from: https://brieflands.com/articles/ijpbs-96715.html.
Roos CR, Carroll KM, Nich C, Frankforter T, Kiluk BD. Short- and long-term changes in substance-related coping as mediators of in-person and computerized CBT for alcohol and Drug Use Disorders. Drug Alcohol Depend. 2020;212:108044.
Comments (0)